3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
103
INDUSTRY
14
OTHER_GOV
3
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Dermatologic
1
Conditions
Melanoma
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Specimen Handling
67
Magnetic Resonance Spectroscopy
52
Cyclophosphamide
44
Vincristine
37
Radiotherapy
30
Radiation
30
Cisplatin
30
Carboplatin
29
Dexamethasone
27
Etoposide
26
Doxorubicin
25
Biopsy
25
daratumumab
17
Radiotherapy, Intensity-Modulated
17
Prednisone
17
Paclitaxel
16
Irinotecan
16
Cytarabine
16
durvalumab
15
Platinum
15
Gemcitabine
15
Observation
14
Methotrexate
14
Leucovorin
14
Docetaxel
14
1,2-diaminocyclohexaneplatinum II citrate
14
Lenalidomide
13
X-Rays
12
Watchful Waiting
12
Rituximab
12
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Immune Checkpoint Inhibitors
×
1 year
×
Clear all
NCT05522660
2026-04-27
USZ-STRIKE
ETOP IBCSG Partners Foundation
Phase 3
Recruiting
180 enrolled